Spine Aesculap Implant Systems Announces the Long-Term Reporting from its Pivotal IDE Trial for the activL® Artificial Disc byChris StewartJuly 26, 2021
Spine Top Stories Five-Year FDA IDE Trial Shows Higher Safety Profile and Greater Effectiveness at Preserving Range of Motion for the activL® Artificial Disc Compared to Previous Generation Lumbar Discs byChris StewartAugust 16, 2019
Spine Top Stories UnitedHealthcare’s New Positive Medical Policy in Favor of Lumbar Total Disc Replacement Reconfirms the Procedure’s Long-Term Effectiveness for Treatment of Degenerative Disc Disease byJosh SandbergJuly 5, 2018
Spine Aesculap Implant Systems Announces U.S. Military’s TRICARE Now Covers Lumbar Total Disc Replacement byJosh SandbergJune 6, 2018
Spine Top Stories Lumbar Artificial Disc Replacement with the activL® Artificial Disc to be More Effective at Delaying the Progression of Adjacent-Level Disease which Spinal Fusion has been Found to Accelerate byJosh SandbergApril 12, 2018
Spine NASS 2017 Best Paper Sessions Provide Significant Insights into the Long-Term Results of activL® Artificial Disc byJosh SandbergNovember 10, 2017
Spine Top Stories New long-term data on the effect of lumbar total disc replacement on adjacent level degeneration reinforces outcomes from previous studies byJosh SandbergMay 8, 2017
